Abstract: Salvinorin A (SalA) is a plant metabolite that agonizes the human kappa-opioid receptor (κ-OR) with high affinity and high selectivity over mu-and delta-opioid receptors.
1
. The number of opioid-related deaths in 2015 surpassed 33,000 2 , which rivaled U.S. motor vehicle fatalities (35,000) 3 ; preliminary estimates from 2016 showed the annual rate continuing to rise 4 . To counter this epidemic, replacement of abused opioids with alternate pain therapeutics has emerged as an increasingly sensible goal 5 . One alternative antinociceptive target under investigation is the kappa-opioid receptor (κ-OR), a G protein-coupled receptor (GPCR) that is expressed throughout the nervous system and modulates consciousness, cognition, mood and pain 6, 7 . κ-OR-targeted analgesic development has focused on chemical property modification to generate peripherally-restricted κ-OR agonists that lack central nervous system (CNS)-associated effects (e.g. hallucination) 8, 9 , or that promote biased signaling to minimize βarrestin-associated effects (e.g. sedation, dysphoria) 10 . Among the more potent and selective agonists of the κ-OR is the brain-penetrant plant metabolite salvinorin A (SalA, 1), which was identified as the primary psychoactive principle of Salvia divinorum and the most potent naturally-occurring hallucinogen ever discovered 11 . As a result, SalA has been subject to semi-synthetic modification 12, 13 and total synthesis [14] [15] [16] [17] to adjust its chemical properties and/or promote biased signaling of the κ-OR. Notably, a thiocyanate analog of SalA, RB-64, was shown to strongly bias towards G protein-coupled signaling 18 . While many semi-synthetic analogs of SalA have been explored, the most prolific investigators recently noted that its "chemical liabilities . . . narrow the available pool of viable chemical transformations." 13 For example, both semi-synthesis and total synthesis encounter the configurational lability of the C8 carbon, which undergoes epimerization to a lower affinity isomer, 8-epi-SalA (154-356-fold loss in potency) 19 . The reaction mechanism has been hypothesized to involve either ring-fragmentation/ reclosure or simple enolization/ reprotonation, with the bulk of evidence pointing to the latter 20 . However, the driving force for this trans-to cis-ring epimerization has not been identified. We believed a combination of lactone planarity and C20 axial-strain to be responsible. Analogy can be drawn to bridgehead (C10) methyl substitution of 1-decalone, which alters its trans:cis equilibrium ratio from 95:5 (C10-H) to 59:41 (C10-Me), driven by relief of the Me-C3-H ax 1,3-diaxial interaction in the cisisomer 21 . In order to stabilize the scaffold and attenuate epimerization, C20 of SalA might be resected through chemical synthesis, whereas semisynthetic removal would be difficult. The effect of this modification on the chemical synthesis itself is profound. We hypothesized that the driving force for this epimerization is partly diaxial repulsion between C20 and H8, which is relieved in the cis-fused isomer, analogous to 10-methyl-1-decalone epimerization. Therefore, like 1-decalone, C20 (methyl) deletion should stabilize the SalA scaffold.
When strategic bonds (SBs) 22, 23 in SalA are considered, the quaternary carbon (C9) bearing the C20 methyl reveals its importance. Two SBs in SalA take priority over other possibilities through the large reduction of complexity associated with their cleavage: a C12-O lactonization transform removes a heteroatom bond, ring and stereocenter, and a C8-9 Michael transform removes a ring and 3 stereocenters, leaving a simple cyclohexanone. However, strategic prioritization of the C9-10 bond ignores stereocontrol, which suffers from the small potential energy calculated to separate sub-targets A-C from stereoisomers X-Z. As a result of the diaxial C19/ C20 methyls, A and C only favor the desired trans-decalone by a slim margin, and alkyne B heavily favors the cis-decalone Y. Notably, the four prior total syntheses avoid decalone intermediates altogether, despite their simplicity. Furthermore, precursor 3 contains a tetrasubstituted neopentyl alkene (C9=10) in which one substituent is a quaternary carbon, which is difficult to form due to A 1,3 strain. In addition to SalA scaffold destabilization, C20 destabilizes intermediate decalones and thus deprioritizes a key strategic bond (C8-9). C20 also frustrates precursor (3) synthesis as a substituent on a tertalkyl tetrasubstituted alkene.
These problems abate if the target is treated not as static but as dynamic. The C9-10 bond becomes strategic for disconnection only by resection of the C20 methyl; C9-10 can be considered a 'dynamic strategic bond.' Three benefits emerge. First, the intermediate trans-decalin (D) is calculated to predominate over the cis-isomer (W), in contrast to A-C vs. X-Z. Second, the unsaturated cyclohexanone precursor would arise from condensation of a β,β-disubstituted cyclohexenolate with an aldehyde instead of a methyl ketone: the latter is a challenging reaction for which we found no precedent. Third, 20-nor-SalA is calculated to be more stable than its C8-epimer, reversing the configurational preferences of SalA itself. Taken together, there is only one reason not to resect C20: 20-nor-SalA is an unknown molecule with unknown binding affinity to the κ-OR.
The prospect of undertaking a total synthesis of a complex molecule for application opioid receptor pharmacology with no guaranteed target affinity was daunting. So, we first explored the binding of 20-nor-SalA to the κ-OR in silico. However, the recent crystal structure of a κ-OR with antagonist JDTic 6 reflects an inactive state conformation of the binding pocket, specific to JDTic, and therefore is not well suited for binding of agonist SalA or its analogs. Therefore, we developed an activelike model of the κ-OR by using homology modeling based on residues. This pose also satisfies the ligand interaction contacts derived from mutagenesis data for SalA 25 . In this pose, the 20- methyl group is directed towards the extracellular region with no apparent interactions with the receptor. This binding pose suggested comparable binding affinity for SalA and its nor-20 derivative.
These calculations provided a theoretical basis for investigation; justification for total synthesis usually depends on experimentally observed activity. However, knowledge of κ-OR affinity in this case required synthesis -a catch-22. A study to probe structure-activity relationships in SalA could not reach the nor-20 target, 26 so no empirical data was available. Nevertheless, we felt the potential benefits for therapeutic development outweighed the risk. Furthermore, the simplification imparted by C20 resection significantly improved material access by unlocking the C9-10 bond, whereas prior syntheses of SalA produced only small amounts of late-stage material over multiple operations (20-29 steps; 0.7-1% yield).
14-17 Shown in Figure 5 is a 10-step synthesis of 20-norSalA.
The synthesis commenced from Hagemann's ester (4), a commercially available building block common in terpene synthesis 27 , which appeared to be an obvious precursor to 20-nor-SalA via vicinal difunctionalization. Grignard reagent 5 was generated from commercially available tert-butyl(4-chlorobutoxy)dimethylsilane and used directly. However, early experiments to trap the sterically-encumbered enolates resulting from conjugate addition proved fruitless, even with the simplest electrophiles like acetaldehyde. Enolate transmetallation with diethylzinc allowed enol silane formation and Mukaiyama aldol addition 28 , but always in low yield and never with electron-rich aldehydes. Instead, we found that addition of zinc chloride 29, 30 and five equivalents of acrolein resulted in efficient formation of 6 as an inconsequential 6:1 mixture of allylic alcohols. Elimination of this alcohol was effected by mesylation, followed by ketone enolization by addition of DBU. These conditions initially delivered a mixture of (E)-and (Z)-dieneones, but isomerization mediated by reversible DBU addition occurred with prolonged reaction time to favor (E)-7 with 20:1 selectivity.
Subsequent steps for elaboration to 20-nor-1 involved careful choreography of 1) cyclization, 2) α-acetoxylation, 3) aryl appendage and 4) lactonization steps, based on extensive reconnaissance briefly discussed here. An initial Heck arylation of 7 with 3-bromofuran or its boronic esters proved low yielding and δ-(3-furyl)-substitution lowered the electrophilicity of the dienone towards nucleophiles. Several ketone α-hydroxylations competitively oxidized the furan ring if present, and Hagiwara's conditions for acetate installation by Mitsunobu stereoinversion 15 were inefficient and required purification from 20 equivalents PPh 3 and 10 equivalents diisopropyl azodicarboxylate. The aldehyde, not carboxylic acid oxidation state, was chosen to engage in Michael addition due to its ease of enolization (or enamine formation) in the presence of the two other enolizable carbonyls. As a result, the final sequence involved tert-butyldimethylsilyl removal with 2 M HCl, followed by Swern oxidation of the deprotected alcohol to aldehyde 8. Intramolecular Michael addition was carried out from the corresponding pyrrolidine enamine in methanol/ tetrahydrofuran with added acetic acid. As the alcoholic cosolvent increased in size, the ratio of trans-and cis-decalone (see Fig. 5B ) increasingly favored the undesired cis-decalin. Quench by potassium carbonate served to equilibrate an initially low ratio of trans-/ cis-decalones to predominantly one isomer 9 (cis-decalone lower than 5% content by crude 1 H NMR), which contained the contiguous stereopentad found in the salvinorin A scaffold. Substitution of methanol co-solvent with ethanol resulted in a dramatically slower equilibration. Pinnick oxidation of aldehyde 9 capped a facile route to diversifiable carboxylic acid (10, X-ray confirmation), which was successfully scaled to 5.3 grams in a single pass. After much experimentation, we found only 4 steps to separate 10 from 20-nor-SalA, affording a convenient platform for eventual diversification to alter the chemical properties of the SalA chemotype. The first two of these steps address appendage of the equatorial acetate, which is challenged by the high selectivity for axial approach of electrophiles 16 , the difficulty of S N 2 stereoinversion of these axial α-hydroxy and α-bromo cyclohexanones, and the high oxidation potential of furanyl intermediates. In some cases, α-debromination by acetate outcompeted substitution. These problems were solved by deprotonation of 10 with 2.1 equivalents of LDA followed by Davis oxaziridine 31 addition, which generated in high diastereoselectivity the axial α-hydroxy-decalone. Subsequent acetylization occurred at both the alcohol and the carboxylic acid; warming this reaction mixture led to equilibration to favor the equatorial acetate without affecting the stereochemistry at any other position. Careful aqueous workup was performed to decompose the mixed anhydride at high pH and recover the carboxylic acid at low pH, while sparing the acetate from cleavage during these operations.
The carboxylic acid itself was found to be crucial for the Heck arylation with 3-bromofuran. Early experiments to arylate the electronically unbiased olefin of aldehyde 9 surveyed a range of palladium sources, oxidants, ligands, solvents and bases, under both oxidative 32 and traditional Heck conditions with little success. The optimal results in these early versions of the synthesis required ten portion-wise additions of palladium(II) acetate, 3-furanylboronic acid, and a bifluoride source. Ultimately, the yield, reproducibility and enthusiasm for this intensive procedure were low. Fortunately, we discovered that carboxylic acids 10 or 11 (in contrast to aldehyde 9) underwent very efficient Heck arylation as their alkali salts: the potassium carboxylate provided the highest yields of 12 and XPhos ligands promoted the highest rates and catalyst turnovers. The superiority of carboxylic acids to the corresponding aldehyde may derive from accelerated coordination/ migratory insertion by initial coordination of the 3-furyl-palladium(II) by the potassium carboxylate (Fig. 5B) . Analogy can be drawn to classic proximity effects 33 recently brought to bear on palladium catalysis using carboxylic acids 34 . To the best of our knowledge, the closest precedent in the Heck reaction of haloarenes 35 involves the accelerated arylation of unsaturated primary amides compared to their corresponding phthalimides 36 .
The final obstacle to 20-nor-1 required lactonization of the carboxylic acid onto an electron-rich conjugated alkene with Markovnikov regioselectivity and equatorial stereoselectivityon its face an uncomplicated scenario. We were dismayed to discover that subjection of 12 to a variety of strong Brønsted acids led to furan decomposition at rates competitive with lactonization, and what little lactones could be recovered were equimolar mixtures of diastereomers at C12. The same lactones were generated in trace quantities by the Heck reaction (11→12), possibly by a Pd-H-mediated pathway 37 , but never in preparatively useful yields, nor with stereoselectivity. Experimentation with radical-polar crossover cyclization 38 and Lewis acid-assisted cyclization honed in on Bi(OTf) 3 in hexafluoroisopropanol (HFIP) solvent as the highest yielding conditions that exhibited good lactonization rate (61%, t 1/2 = 30 mins at 0 °C), but no stereoselectivity. We were surprised to find that HFIP solutions of 12 in the absence of any Lewis acids underwent lactonization, albeit with substantially decreased rates (t 1/2 = 3.5 days at 40 °C). These were the only conditions to exhibit stereochemical preference for 20-nor-1 (4:1 d.r. @ 63% conversion). Neither trifluoroethanol (TFE, pKa = 12.4) 39 nor nonafluoro-tert-butanol (pKa = 5.2) promoted efficient lactonization, even at elevated temperature (90 °C), highlighting the idiosyncracy of HFIP (pKa = 9.3). Weak and moderate Brønsted acids (CH 3 CO 2 H, pKa = 4.8; phenol, pKa = 10; CF 3 CO 2 H, pKa = -0.25) did not cause any reaction at room temperature, whereas strong Brønsted acids (CF 3 SO 3 H, pKa = -14) caused non-stereoselective lactonization concomitant with decomposition. The lactonization is reversible in HFIP: at elevated temperatures 20-nor-1 equilibrates to 12 and 12-epi-20-nor-1 with no stereoselectivity but favoring the lactones. Therefore, the stereoselectivity imparted by HFIP is not thermodynamic but kinetically determined. All of these observations exclude an intermolecular alkene protonation by HFIP, and instead may derive from acidification of the substrate carboxylic acid via a hydrogen bonding network, followed by internal protonation and collapse of the ion pair (Fig. 5B) . For preparative purposes, we have found it easiest to generate 20-nor-1 with high conversion from 12, but with low stereoselectivity since 12-epi-20-nor-1 is easily separable. Alternatively, we can halt these reactions at low conversion and good stereoselectivity (e.g. 63%, 4:1 d.r.), which may be useful for analogs whose diastereomers are inseparable.
Access to 20-nor-1 allowed us to compare its chemical reactivity and biological activity to 1. As reported by multiple investigators, SalA is undergoes epimerization under basic conditions to disfavor the natural configuration at C8. Similarly, we found 0.5 equivalents of DBU in d 3 -acetonitrile generates a 29:71 mixture of 1:8-epi-1 at 80 °C ( Figure 6 ). In contrast, this relative stability is reversed in 20-nor-SalA: under identical conditions the equilibrium holds at 70:30, close to the calculated K eq (Figure 3 ). More importantly, 20-nor-SalA retains high affinity for the κ-OR, as measured by radioligand competition binding against [ 3 H]-U69,593. It also behaves as a full agonist in G protein signaling assays measured by the inhibition of forskolin-stimulated, adenylyl cyclase-mediated, cAMP accumulation. The pharmacological properties of 20-nor-SalA closely match the conventional, selective agonist U69,593, although SalA has slightly higher affinity and efficacy than either ( Figure 6B ). While we consider our chemical synthesis to be more useful for scaffold diversification than for large-scale production, its brevity has allowed us to prepare enough material (>75 mg) to test its properties in vivo. κ-OR agonists suppress non-histamine-related itch in rodents and in humans, so we evaluated the ability of 20-nor-1 to suppress itch in mice, and found it similarly effective to SalA and another conventional agonist (U50,488H) ( Figure 6C ) indicating a functional equivalence. Preliminary proof-of-principle for the generality of this route, especially the late stage carboxylate-accelerated Heck reaction and alkene lactonization, was established by the synthesis of aryl analogs that have been inaccessible by semisynthetic modification of isolated 1 (Figure 6D ). For example, a thiophene has never been substituted for the naturally-occurring furan, as in 13, which exhibits high binding affinity but reduced agonism compared to 20-nor-1. Similarly, purely unsubstituted phenyl analogs of 20-nor-1 (14) retain the same binding affinity as their furyl counterparts, even the C12-epimer of 14. This observation stands in contrast to prior analogs formed by cycloaddition of dimethylacetylene dicarboxylate with 1 whose disubsituted phenyl rings led to 31-39 fold losses in binding affinity 43 . None of our analogs show appreciable binding to the alternative µ-or δ-opioid receptors (µ-OR/ δ-OR), maintaining the high receptor selectivity of 1. Thus, a small handful of analogs has already opened opportunities for scaffold alteration, and this information should aid the design of analogs with modified physical properties 44 . As demonstrated here, the integration of structure perturbation, in silico docking and retrosynthetic analysis can advance the use of complex secondary metabolites (natural products) as drug leads (Figure 7 , visualized using the Rubik's Cube analogy, as in Ref. 45 ). The attributes of secondary Iterative computation could accelerate deployment of complex metabolites as drug leads. First, random structural mutation of a complex scaffold would generate an ensemble of equally complex analogs. Second, in silico docking using a validated computational model would screen out poor binders and generate an enriched ensemble. Third, retrosynthesis search algorithms would identify scaffolds from among this enriched ensemble that maintain the high structural complexity of the natural product (secondary metabolite), but possess reduced synthetic complexity. A medicinal chemistry campaign to optimize properties would thus be accelerated by facile total synthesis.
metabolites have been embraced as useful library characteristics, especially high-fraction sp 3 content, improving selectivity and hit rate 46, 47 . These same attributes can lead to arduous synthesis campaigns, and have prompted scaffold redesign to significantly reduce complexity 48 . While structural complexity and synthetic complexity are related, they are nonidentical: synthesis can be simplified while structural complexity is maintained 48, 49 . We hope to use the approach demonstrated here-calculated affinity/ dynamic retrosynthetic analysis-to minimally perturb complexity 50 and affinity, only enough to reveal the most efficient retrosynthetic path. A docking program coupled to traditional retrosynthesis search algorithms 23, 45 might easily be deployed against many complex metabolites with known targets. Although restricted to a single illustration, this approach has proved successful for the salvinorin chemotype of κ-OR agonist. By deletion of a single methyl group (C20), identified here as the primary driving force for C8 epimerization, we have simultaneously stabilized the salvinorin scaffold and simplified its synthesis, while maintaining target engagement. This chemical platform includes a carboxylate-directed Heck reaction and an unusual fluorous alcohol-promoted lactonization, which are capable of generating previously inaccessible analogs that retain high potency at the κ-OR and high selectivity against other opioid receptors. Additional modification of the 20-nor-SalA scaffold will focus on improvement of half-life in blood, bioavailability, peripheral nervous system restriction, and bias against βarrestin recruitment, as well as further scaffold stabilization. Success in these goals should deliver multiple candidates for next generation analgesics.
Synthetic methods. All reactions were carried out under positive pressure of argon in a well-ventilated fume hood unless otherwise noted. Reactions were monitored by thin layer chromatography (TLC) using precoated silica gel plates from EMD Chemicals (TLC Silica gel 60 F 254 ). Flash column chromatography was performed over Silica gel 60 (particle size 0.04-0.063 mm) from EMD chemicals. Mass spectra were recorded on an Agilent 6120 Quadrupole LC/MS system with an ESI probe unless otherwise noted. EI MS analysis was performed on Agilent 7820A/5975 GC/MSD system with helium as the carrier gas.
1 H NMR and 13 C NMR spectra were recorded on Bruker DPX-400 and Bruker DRX-600 (equipped with cryoprobe) spectrometers using residual solvent peaks as internal standard (CDCl3 @ 7.26 ppm 1 H NMR, 77.06 ppm 13 C NMR; CD 3 CN @ 1.94 ppm 1 H NMR).
Cell based signaling assays. The competition binding studies were performed on CHO-K1 cells expressing the human KOR (CHO-hKOR) 41 , as described 42 Chloroquine phosphate-induced pruritus. Experiments were carried out with 10-14 week male C57BL/6J mice purchased from The Jackson Laboratory. Mice were group housed (3-5 mice/cage) and maintained on a 12-hour light/dark cycle. All mice were cared for in accordance to the guidelines set forth by the National Institutes of Health and with the approval of The Scripps Research Institute Animal Care and Use Committee. The ability of the agnoists' to block chloroquine phosphate (Sigma Aldrich) induced pruritus was evaluated as previously described (19, 40) . Mice were habituated to the testing boxes for 1 hour and then pretreated with either vehicle (1:1:8, DMSO: Tween 80: 0.9% sterile saline) or 3 mg/kg U50,488H or salvinorin A, or 20-nor-SalA (10 µl/g, s.c.-flank) for 10 minutes. Mice were then challenged with 40 mg/kg chloroquine phosphate (5 µl/g, s.c.-neck) and the number of scratching bouts were counted in 5 minute intervals for 1 hour by a blinded investigator. Data and statistical analysis. Data were analyzed using GraphPad Prism 6.0h software. For each individual cell based assay, compounds were run in duplicate (binding) or triplicate (cAMP) and normalized to the U69,593 response. Dose response curves were generated using three-parameter nonlinear regression analysis. Data are from n ≥ 3 independent experiments and are presented as mean ± S.E.M. Data Availability. The authors declare that the data supporting the findings of this study are available within the paper and its supplementary information files. Raw data files, like NMR fids, are available from the corresponding author upon reasonable request. Materials. Hexanes (ACS grade), ethyl acetate (ACS grade), toluene (ACS grade), and diethyl ether (anhydrous ACS grade) were purchased from Sigma-Aldrich and used without further purification. Dichloromethane (ACS grade), acetonitrile (ACS grade), and chloroform (ACS grade) were purchased from Fisher Chemical and used without further purification. Anhydrous tetrahydrofuran was purchased from Sigma-Aldrich and used without further purification. Anhydrous HMPA was distilled from calcium hydride (10% w/v) through a frit of steel wool under reduced pressure. Anhydrous zinc chloride was dried by stirring at 150 °C under reduced pressure for several hours. Acrolein was distilled under reduced pressure and collected at -78 °C. Anhydrous dichloromethane was distilled from calcium hydride (10% w/v) under positive pressure of argon or obtained by passing the previously degassed solvent through an activated alumina column. Anhydrous triethylamine was purchased from Sigma-Aldrich and used without further purification. Anhydrous methanesulfonyl chloride was distilled from phosphorus pentoxide (10% w/v) under reduced pressure. Anhydrous DBU was distilled from calcium hydride (10% w/v) through a frit of steel wool under reduced pressure. Anhydrous dimethylsulfoxide was purchased from Sigma-Aldrich and used without further purification. Anhydrous methanol was obtained by passing the previously degassed solvent through an activated alumina column. Anhydrous potassium carbonate was dried at 200 °C for at least 12 hours. Anhydrous diisopropylamine was distilled from calcium hydride (10% w/v) under positive pressure of Argon. n-Butyllithium was titrated with a solution of recrystallized diphenylacetic acid in anhydrous tetrahydrofuran. Acetic anhydride was distilled from potassium carbonate under positive pressure of argon. Anhydrous acetonitrile was distilled from phosphorus pentoxide (10% w/v) under positive pressure of argon. Anhydrous DMF was purchased from Sigma-Aldrich and used without further purification. 3-bromofuran was passed through a 3 cm plug of neutral aluminum oxide. Anhydrous hexafluoroisopropanol was stirred over calcium hydride (10% w/v) for 30 minutes, then distilled under positive pressure of argon. Commercially available reagents were used without further purification unless otherwise noted. The reference compounds U69,593 was purchased from Sigma Aldrich and was prepared in ethanol as a 10 mM stock. NorBNI (nor-Binaltorphimine dihydrochloride; Sigma Aldrich), U50,488H (Tocris), salvinorin A (Enzo Life Sciences) and the salvinorin A analogs were prepared as 10 mM stocks in DMSO.
